15 results
8-K
EX-99.1
IVVD
Invivyd Inc
7 May 24
Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19
7:38am
Leukemia) Society. “For people who develop a COVID-19 infection, today’s treatment options are not always adequate or clinically appropriate, especially
8-K
EX-99.1
x9zekym er19y
13 May 22
Adagio Therapeutics Reports First Quarter 2022 Financial Results
7:00am
10-K
85jpcm l7z
31 Mar 22
Annual report
8:18am
8-K
EX-99.1
vcyta34om4ql9pnh
29 Sep 21
Adagio Therapeutics Announces New Data Highlighting the Potential of ADG20 for Treatment and Prevention of COVID-19
4:41pm
10-Q
7afmfgomb lq6cvve3s
20 Sep 21
Quarterly report
4:17pm
424B4
9wf9ue7d9 aan
6 Aug 21
Prospectus supplement with pricing info
4:54pm
S-1/A
u5bgv
2 Aug 21
IPO registration (amended)
6:20am
S-1
ezecr9ow3taq89
16 Jul 21
IPO registration
4:56pm
DRS/A
qic2vdi00amwqy23xipj
28 Jun 21
Draft registration statement (amended)
12:00am
DRS
dxs78zduxqyxaunwga2r
21 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next